Live Nation Entertainment (LYV)
(Delayed Data from NYSE)
$94.66 USD
+6.39 (7.24%)
Updated May 3, 2024 04:00 PM ET
After-Market: $94.66 0.00 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
C Value C Growth A Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$94.66 USD
+6.39 (7.24%)
Updated May 3, 2024 04:00 PM ET
After-Market: $94.66 0.00 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
C Value C Growth A Momentum B VGM
Zacks News
5 Stocks with Upgraded Broker Ratings Worth Considering
by Zacks Equity Research
For retail investors, it's not an easy task to choose stocks that offer steady returns. Therefore, some broker advice comes in handy.
Can Mohawk Industries (MHK) Pull a Surprise in Q2 Earnings?
by Zacks Equity Research
Mohawk Industries (MHK) acquisitions, productivity improvements and introduction of distinctive collections bode well. However, currency headwinds and rise in raw material costs may hamper results.
Can Melco Resorts (MLCO) Pull Off a Surprise in Q2 Earnings?
by Zacks Equity Research
Better performance at the non-gaming segments is likely to drive Melco Resorts & Entertainment Limited's (MLCO) Q2 results. Concerns linked to the sustainability of revenues from the VIP market linger.
Mattel (MAT) Q2 Earnings: Is it Likely to Disappoint?
by Zacks Equity Research
Mattel, Inc.'s (MAT) focus on improving point of sale through new product launches bode well for revenue growth but rising expenses and forex translations could hamper second-quarter results.
What's in the Cards for Hilton (HLT) this Earnings Season?
by Zacks Equity Research
Despite forex headwinds, strong unit development and tremendous growth in loyalty program is likely to drive Hilton Worldwide Holdings Inc.'s (HLT) results in the second quarter.
Zacks.com featured highlights: Live Nation Entertainment, NeoGenomics, Salesforce.com, Paycom Software and Covanta Holding
by Zacks Equity Research
Zacks.com featured highlights: Live Nation Entertainment, NeoGenomics, Salesforce.com, Paycom Software and Covanta Holding
5 Toxic Stocks to Abandon or Play Short for Profit
by Zacks Equity Research
The high price of the toxic stocks can be attributed to either an irrational exuberance associated with them or some serious fundamental drawbacks in the stock.
Can Hasbro (HAS) Spring a Surprise this Earnings Season?
by Zacks Equity Research
Strategic partnerships, rapid growth in emerging markets along with various sales-building initiatives should drive Hasbro, Inc.'s (HAS) top and bottom line in the to-be-reported quarter.
3 Stocks Hitting the Right Note on World Music Day
by Sweta Killa
Since returns are music to investors' ears, there's no better way for us to observe World Music Day than with lucrative picks from companies involved in this business.
Zacks.com featured highlights: Etsy, Live Nation Entertainment, Salesforce.com, Vertex Pharmaceuticals and NeoGenomics
by Zacks Equity Research
Zacks.com featured highlights: Etsy, Live Nation Entertainment, Salesforce.com, Vertex Pharmaceuticals and NeoGenomics
5 Toxic Stocks to Discard or Play Short for Profit
by Zacks Equity Research
If you can pinpoint the toxic stocks accurately, you may gain by resorting to an investing strategy called short selling.
Zacks.com featured highlights: Salesforce.com, Vertex Pharmaceuticals, Live Nation Entertainment, Covanta Holding and Etsy
by Zacks Equity Research
Zacks.com featured highlights: Salesforce.com, Vertex Pharmaceuticals, Live Nation Entertainment, Covanta Holding and Etsy
5 Toxic Stocks to Offload or Play Short for Profit
by Zacks Equity Research
Just like identifying stocks with growth potential, spotting toxic stocks and abandoning them at the right time is the key to protect your portfolio from big losses or make profits by short selling them.
5 Toxic Stocks to Steer Clear Of or Play Short Right Now
by Zacks Equity Research
High price of the toxic stocks can be ascribed to an irrational exuberance associated with them or some serious fundamental lacunae. Presence of such stocks in your portfolio may result loss of wealth.
The Zacks Analyst Blog Highlights: Live Nation Entertainment, Malibu Boats, Hilton Grand Vacations, UnitedHealth Group and WNS
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Live Nation Entertainment, Malibu Boats, Hilton Grand Vacations, UnitedHealth Group and WNS
The Market's Earnings Support
by Sheraz Mian
The positive picture emerging from the Q1 earnings season is providing stocks a tangible fundamental support.
Is a Surprise Coming for Live Nation Entertainment (LYV) This Earnings Season?
by Zacks Equity Research
ASurprise might be Coming for Live Nation Entertainment (LYV) stock on the back of its favorable Zacks Rank and positive ESP.
Zacks.com featured highlights: PTC, Covanta Holding, Live Nation Entertainment, Incyte and Vertex Pharmaceuticals
by Zacks Equity Research
Zacks.com featured highlights: PTC, Covanta Holding, Live Nation Entertainment, Incyte and Vertex Pharmaceuticals
5 Toxic Stocks to Shun or Play Short Right Now
by Zacks Equity Research
Just like picking up stocks with strong growth potential, pinpointing toxic stocks and abandoning them at the right time is the key to protect your portfolio from big losses or make profits by short selling them.
AMC Entertainment (AMC) Beats on Q4 Earnings and Revenues
by Zacks Equity Research
AMC Entertainment Holdings Inc. (AMC) reported strong financial results in the fourth quarter of 2016 wherein both the top line and the bottom line outpaced the Zacks Consensus Estimate.
Zacks.com featured highlights: Abercrombie & Fitch, Live Nation Entertainment, Vertex Pharmaceuticals, Etsy and Incyte
by Zacks Equity Research
Zacks.com featured highlights: Abercrombie & Fitch, Live Nation Entertainment, Vertex Pharmaceuticals, Etsy and Incyte
5 Toxic Stocks to Abandon or Play Short Right Now
by Zacks Equity Research
In general, toxic stocks are burdened with huge debt loads and vulnerable to external shocks.
What to Expect from Live Nation (LYV) this Earnings Season?
by Zacks Equity Research
Live Nation Entertainment, Inc. (LYV) is scheduled to report fourth-quarter and full-year 2016 numbers on Feb 23, after the market closes
Zacks.com featured highlights: Live Nation Entertainment, Conns, ConocoPhillips, Etsy and Incyte
by Zacks Equity Research
Zacks.com featured highlights: Live Nation Entertainment, Conns, ConocoPhillips, Etsy and Incyte
5 Toxic Stocks to Dump or Play Short Now
by Zacks Equity Research
Higher price of the toxic stocks can be attributed to either an irrational exuberance associated with them or some serious fundamental lacuna.